Articles by Disease (Colorectal Cancers)

Rational Combination of Targeted Therapies As A Strategy to Overcome The Mechanisms of Resistance to Inhibitors of EGFR Signaling

Journal: Current Pharmaceutical Design
Volume: 13
Page: 3358-3367
Author(s): Roberto Bianco, Vincenzo Damiano, Teresa Gelardi, Gennaro Daniele, Fortunato Ciardiello and Giampaolo Tortora

Thioredoxin and Thioredoxin Reductase As Redox-Sensitive Molecular Targets for Cancer Therapy

Journal: Current Pharmaceutical Design
Volume: 13
Page: 3368-3377
Author(s): J. Daniel Pennington, Kristi Muldoon Jacobs, Lunching Sun, Gil Bar-Sela, Mark Mishra and David Gius

Valproic Acid As Anti-Cancer Drug

Journal: Current Pharmaceutical Design
Volume: 13
Page: 3378-3393
Author(s): Martin Michaelis, Hans Wilhelm Doerr and Jindrich Cinatl Jr.

Anticancer Drugs Designed by Mother Nature: Ancient Drugs but Modern Targets

Journal: Current Pharmaceutical Design
Volume: 13
Page: 3400-3416
Author(s): Haruyo Ichikawa, Yutaka Nakamura, Yoshiki Kashiwada and Bharat B. Aggarwal

Connecting A Tumor to the Environment

Journal: Current Pharmaceutical Design
Volume: 13
Page: 3440-3444
Author(s): Frank Entschladen, Daniel Palm, Theodore L. Drell IV,, Kerstin Lang and Kurt S. Zaenker

Pathobiology of Head and Neck Squamous Tumorigenesis

Journal: Current Cancer Drug Targets
Volume: 7
Page: 606-612
Author(s): Adel K. El-Naggar

Exploration of Metastasis-related Proteins as Biomarkers and Therapeutic Targets in the Treatment of Head and Neck Cancer

Journal: Current Cancer Drug Targets
Volume: 7
Page: 613-622
Author(s): Zhuo (Georgia) Chen